|Published||Report Code||Available Format||Pages|
Valued at $2,010.2 million in 2019, the global antimicrobial additives market size is projected to witness a CAGR of 7.5% during the forecast period (2020–2030). A multitude of economic and technological factors, including growth in the healthcare industry and integration of advanced technologies in product manufacturing, along with the threat of bio-resistance in patients due to the excessive administration of antibiotic drugs, are driving the antimicrobial additives industry.
In 2019, the inorganic antimicrobials bifurcation accounted for a larger size than their organic counterparts. This has been attributed to the non-toxic and other favorable chemical attributes of zinc-, copper-, and silver-based antimicrobial formulations, over their organic counterparts. Furthermore, the widespread adoption of these products in food and non-food consumer goods, packaging, and compounding in a differentiated array of products is expected to drive the antimicrobial additives market in the upcoming period.
The healthcare sector accounted for the largest size, among all end-use industries, in 2019. Additionally, the market is likely to continue on its high-growth trajectory, outperforming all other possible application areas and end-use industries, in the foreseeable future. The primary driver for the demand for antimicrobial additives in this industry is the growing prevalence of nosocomial infections or hospital-associated infections (HAIs).
Documented research across North America and Europe has indicated high rates of HAI transmission, which has a significant physiological and economic impact. Owing to such factors, the consumption of the compounds is projected to increase, thereby boosting the antimicrobial additives market growth.
Across other regions, the effects of HAI’s are more profound, due to the compromised hygiene standards, thereby often having fatal outcomes. These factors, along with the heightened public awareness on hygiene, are likely to drive the antimicrobial additives market during the forecast period.
In the wake of COVID-19, supply chain uncertainties and temporary suspension in manufacturing during the initial days were countered by the demand for such additives in healthcare equipment. Government contracts are being secured by market players to assist healthcare professionals in fighting the pandemic.
During the historical period (2014–2019), North America created the largest demand in the antimicrobial additives market. The North American healthcare ecosystem has been at the receiving end of HAIs’ rampage in recent years. The regular administration of individuals with antibiotics has led to increasing instances of bio-resistance, with doctors finding it increasingly tougher to combat the spread of virulent strains of diseases. This, coupled with a fair degree of purchasing power and the ability to increase the price points of regular-use products, has allowed manufacturers to integrate these additives in various products, with clean-label ingredients becoming increasingly commonplace across the packaging and healthcare industries in the region.
The higher adoption of antimicrobial agents across the consumer goods and food and beverage supply chains in the U.S. and Canada is further expected to rake in an additional demand in the foreseeable future, in turn, propelling the antimicrobial additives market.
The rising incidence of medical implants among patients, due to a significant number of cardiovascular disease cases and growth of the healthcare sector, is identified as a key factor driving the APAC antimicrobial additives industry growth.
Furthermore, technological advancements across end-use industries, such as food and beverages and packaging, are likely to generate a high-volume demand for bio-resistant products in the coming years. This is likely to be driven by the increasing pressure from consumers and mass-mobilization of supply chains toward safe packaging, in cue with North American and European markets. Owing to these factors, several end-use industries are expected to integrate these additives across conventional product manufacturing lines.
The mainstream administration of antibiotics in patients, to treat and reduce the risk of fungal and bacterial infections, had led to the increasing possibility of the emergence of stronger and, to a fair degree, highly-resistant pathogens. Furthermore, the problem is more compounded when disinfection chemicals are used, as they are likely to have irregular activity and do not offer long-lasting protection. The integration of antimicrobials during the manufacturing of products can offer a solution to this conundrum. In due course, this performance attribute would be the primary factor forecast to make the addition of antimicrobial additives across product manufacturing lines a mainstream trend in future.
A multitude of factors, ranging from the growing aging population and prevalence of chronic diseases to the expansion of healthcare systems in developing countries, is bringing growth to the global healthcare industry. The mainstream adoption of novel drugs, technologies, and even accessories and the integration of products such as antimicrobial additives are expected to act as part of the technology shift in the industry.
This is expected to drive public and private investments in the sector and make stakeholders increasingly adopt these advanced formulations, thereby generating a bullish outlook for antimicrobial-integrated products across European and North American countries. This would even provide traction to the antimicrobial additives market in other geographies during the foreseeable future.
|Base Year (2019) Market Size||$2,010.2 million|
|Forecast Period (2020-2030) CAGR||7.5%|
|Report Coverage||Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Company Share Analysis, Companies’ Strategical Developments, Company Profiling|
|Market Size by Segments||Type, End-Use Industry, Geography|
|Market Size of Geographies||U.S., Canada, Germany, France, Italy, U.K., Spain, Russia, Japan, China, India, South Korea, Brazil, Mexico, Argentina, Turkey|
|Secondary Sources and References (Partial List)||Centers for Disease Control and Prevention (CDC), European Directorate for the Quality of Medicines and Healthcare (EDQM), National Center for Biotechnology Information (NCBI), World Bank, World Health Organization (WHO)|
The moderately fragmented antimicrobial additives market is characterized by the presence of large chemical companies and new startups aiming to gain acclaim in niche application areas and certain geographies. Some of the large players operating in the antimicrobial additives industry are AkzoNobel N.V., Milliken Chemical Company, DuPont de Nemours Inc., and BASF SE. Other players in the antimicrobial additives market are Momentive Performance Materials Inc., RTP Company, Microban International Ltd., BioCote Limited, Sanitized AG, and Sciessent AG.
Dupont de Nemours Inc. accounted for the largest share in the antimicrobial additives market in 2019. The company leverages its strong chemical production lines, of metal-working fluids, adhesives, construction chemicals, paints and coatings, and textile chemicals, and intellectual property to offer products that have a high degree of compatibility with its complementary products.
In recent years, players in the antimicrobial additives market have initiated partnerships and acquisitions and launched a number of new and advanced products, in order to stay ahead of their competitors. For instance:
The antimicrobial additives market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.
Based on Type
Based on End-Use Industry